By Counterforce Health Team in Revcovi (elapegademase) —

How Long Does It Take to Get Revcovi (elapegademase) Approved by Cigna in California? Complete Timeline Guide

Answer Box: Getting Revcovi Covered by Cigna in California

Cigna covers Revcovi (elapegademase) for ADA-SCID with prior authorization, typically deciding within 5 business days for standard requests or 24 hours for urgent cases. The fastest path requires your immunologist to submit complete documentation: confirmed ADA enzyme deficiency (<1% normal) or genetic testing, specialist prescription, and dosing ≤0.4 mg/kg/week. If denied, California's Independent Medical Review (IMR) provides strong patient protections with a 73% overturn rate. Start today by having your doctor verify your ADA-SCID diagnosis documentation and prepare the Cigna California PA form.

Table of Contents

What Affects Approval Timing

Several factors determine how quickly Cigna approves Revcovi coverage in California:

Benefit Structure: Cigna manages specialty drugs like Revcovi through Express Scripts and Accredo specialty pharmacy. This adds coordination steps but provides specialized review expertise for rare disease therapies.

Criteria Complexity: Cigna's medical necessity criteria for Revcovi are specific but straightforward—confirmed ADA-SCID diagnosis, specialist prescription, and appropriate dosing limits.

Documentation Completeness: The most common cause of delays is incomplete initial submissions. Missing ADA enzyme activity results, genetic testing, or specialist consultation notes can add 1-2 weeks to the process.

Note: California law provides automatic approval ("deemed approved") if Cigna doesn't respond within 72 hours for standard requests or 24 hours for urgent cases.

Pre-Submission Preparation (0-2 Days)

Essential Documentation Checklist

Before your doctor submits the prior authorization, gather these required documents:

Diagnostic Evidence (Required):

  • ADA enzyme activity test showing <1% of normal baseline activity, OR
  • Molecular genetic testing confirming bi-allelic pathogenic variants in the ADA gene
  • ICD-10 diagnosis code D81.31 (ADA-SCID)

Specialist Requirements:

  • Prescription from or consultation with immunologist, hematologist/oncologist, or ADA-SCID specialist
  • Clinical notes documenting SCID presentation and treatment rationale

Clinical History:

  • Newborn screening results (abnormal TREC if available)
  • Infection history and severity
  • Imaging showing absent thymic shadow
  • Documentation of why alternatives (bone marrow transplant, gene therapy) aren't suitable

Verify Insurance Details

Call Cigna customer service at 800-244-6224 to confirm:

  • Your plan's specialty drug coverage
  • Whether Revcovi requires step therapy (it typically doesn't for ADA-SCID)
  • Your current deductible and specialty tier copay

Submission to Initial Review (1-5 Days)

How to Submit

Your doctor has three options for submitting the prior authorization:

  1. Electronic Submission (Fastest): Via cignaforhcp.com provider portal
  2. Fax: Complete California General Medication PA Form to 800-390-9745
  3. Phone: Call Express Scripts at 800-835-3784 for urgent cases

California Timeline Rules

Under California law, Cigna must:

  • Respond within 5 business days for standard requests
  • Respond within 24 hours for exigent (urgent) circumstances
  • Automatically approve if no response within these timeframes
Tip: Mark requests as "exigent" if you have active infections, declining immune function, or are currently receiving temporary enzyme replacement.

What Reviewers Check First

Cigna's utilization management team verifies:

  1. Confirmed ADA-SCID diagnosis with lab evidence
  2. Specialist involvement in care
  3. Appropriate dosing (≤0.4 mg/kg/week intramuscularly)
  4. No contraindications or safety concerns

Additional Information Requests (1-7 Days)

If Cigna requests additional information, respond within 14 days to avoid automatic denial. Common requests include:

Missing Lab Results: ADA enzyme activity must be documented as <1% of normal Specialist Clarification: May need formal consultation note from immunologist Dosing Justification: If requesting higher than standard doses, provide clinical rationale

How to Respond Quickly

  • Use the same submission method as your original request
  • Include your original PA reference number
  • Have your doctor's office call 800-244-6224 to confirm receipt

Decision Window & Reading Your Results

Approval Letters

If approved, you'll receive written confirmation within 1-2 business days stating:

  • Authorized duration (typically 12 months)
  • Approved dosing and frequency
  • Specialty pharmacy instructions (usually Accredo)

Coverage Begins

Once approved, coverage is effective immediately. Your prescription will be routed to Cigna's specialty pharmacy network for fulfillment.

If Denied: California Appeal Options

California provides some of the strongest patient appeal rights in the country. If Cigna denies your Revcovi request, you have multiple escalation paths.

Internal Appeal (Required First Step)

File a grievance with Cigna within 180 days of the denial notice:

  • Call 800-882-4462 or submit via myCigna.com
  • Include additional clinical documentation
  • Request peer-to-peer review with a specialist familiar with ADA-SCID

Cigna has 30 days to respond to internal appeals.

Independent Medical Review (IMR)

If the internal appeal is denied, California's Department of Managed Health Care (DMHC) provides Independent Medical Review at no cost to you.

Timeline: Submit IMR request within 6 months of Cigna's final denial Process: Independent physicians review your case using evidence-based medicine Success Rate: 73% of IMRs result in patients receiving the requested service Decision Timeline: 30 days for standard review, 3 days for expedited

To request IMR:

  • Complete the DMHC IMR application online
  • Include all denial letters and medical records
  • Call DMHC Help Center at 888-466-2219 for assistance
From our advocates: We've seen many ADA-SCID cases initially denied for "lack of medical necessity" successfully overturned at IMR when families provided comprehensive genetic testing results and specialist letters explaining why bone marrow transplant wasn't viable. The key is thorough documentation of the diagnosis and treatment rationale.

When to Contact State Regulators

If Cigna doesn't follow required timelines or denies coverage despite meeting their published criteria, contact:

  • DMHC Help Center: 888-466-2219
  • File a complaint at dmhc.ca.gov

Renewal Cycles & Reauthorization

Initial Authorization Duration

Cigna typically approves Revcovi for 12 months initially. Your doctor will receive notification 60-90 days before expiration.

Reauthorization Requirements

For renewal, your doctor must document:

  • Continued medical necessity (ongoing ADA-SCID)
  • Beneficial response to treatment (improved ADA activity, dAXP levels, lymphocyte counts)
  • No serious adverse events requiring discontinuation
  • Ongoing specialist oversight

Timing Your Renewal

Submit reauthorization requests 30 days before expiration to avoid coverage gaps. The renewal process typically takes 3-5 business days if documentation is complete.

Timeline Visual: Key Milestones

Milestone Standard Timeline Expedited Timeline Your Action
Pre-submission prep 0-2 days Same day Gather documentation
Initial submission Same day Same day Doctor submits PA
Cigna review 1-5 business days 24 hours Track status
Additional info request 1-7 days if needed Same day Respond quickly
Final decision Within 5 business days total Within 24 hours Review approval letter
Internal appeal (if denied) 30 days 3 days File with Cigna
IMR (if needed) 30 days 3 days File with DMHC

Time-Saving Tips for Faster Approval

Use Electronic Submission: The Cigna provider portal processes requests faster than fax or mail.

Bundle All Evidence: Include genetic testing, enzyme activity results, and specialist notes in the initial submission to avoid back-and-forth requests.

Leverage Specialty Routing: Have your immunologist submit directly rather than routing through primary care, as specialists familiar with rare diseases often get faster review.

Track Proactively: Check status weekly through your doctor's office or myCigna.com rather than waiting for notification.

Prepare for Renewal Early: Start the reauthorization process 45-60 days before expiration, not 30 days.

FAQ: Common Questions

How long does Cigna prior authorization take for Revcovi in California? Standard requests: up to 5 business days. Urgent requests: within 24 hours. California law requires automatic approval if Cigna doesn't respond within these timeframes.

What if Revcovi isn't on my Cigna formulary? Cigna covers Revcovi for ADA-SCID with prior authorization regardless of formulary status. Your doctor can request a formulary exception if needed, with decisions within 72 hours.

Can I request an expedited appeal? Yes, if you have a health condition that may seriously jeopardize your life or health, or if you're currently using Revcovi. Expedited appeals are decided within 3 days.

Does step therapy apply if I've failed treatments outside California? Step therapy documentation from other states is typically accepted. Include records of prior treatment failures or contraindications to alternatives.

What happens if my doctor isn't an immunology specialist? Cigna requires prescription by or consultation with an immunologist, hematologist/oncologist, or ADA-SCID specialist. Your primary doctor can coordinate with a specialist for the required consultation.

How much will Revcovi cost with Cigna coverage? Costs vary by plan, but expect specialty tier copays ranging from $100-500+ per month. Check your specific plan documents or call Cigna for exact costs.

Getting help with complex appeals: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and drafts point-by-point rebuttals aligned to each payer's specific criteria, pulling the right clinical evidence and citations to support coverage requests for specialty medications like Revcovi.

For additional support with your Revcovi coverage journey, Counterforce Health provides specialized expertise in rare disease coverage appeals, helping families navigate complex prior authorization requirements and appeal processes when initial requests are denied.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and is not medical advice. Coverage decisions depend on your specific plan benefits and clinical circumstances. Always consult with your healthcare provider and insurance plan for guidance specific to your situation. For assistance with appeals or coverage questions, contact the California Department of Managed Health Care at 888-466-2219.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.